参考文献/References:
[1]沈秉正,宋金春,彭燕,等.IL-17在幽门螺旋杆菌感染相关消化道疾病中的作用[J].海南医学,2016,27(1):100-103. [2]Meucci G,Tatarella M,Vecchi M,et al.High prevalcnce of Ielicobacter pylori infection in patients with colonic adcnomas and carcinomas[J].J Clin Gastroenterol,1997,25(4):605-607. [3]李铿,孙达龙.幽门螺旋杆菌感染与结直肠腺瘤性息肉的相关性研究[J].临床医学,2019,39(11),44-46. [4]潘程宇,滑永志.幽门螺旋杆菌感染与大肠息肉的相关性[J].临床与病理,2020,40(3):616-619. [5]涂宏飞,费素娟.结直肠息肉与幽门螺杆菌分型及血清胃泌素17的关系[J].中国综合临床,2019,35(6):544-548. [6]徐莹,张金华,刘志平.大肠息肉发病相关危险因素Logistic分析[J].临床消化病杂志,2017,29(6):379-382. [7]王鹤.结直肠息肉、代谢异常综合征及幽门螺旋杆菌感染的相关性分析研究[D].吉林大学,2017. [8]唐斌,张俊,唐友攀,等.幽门螺杆菌感染与结肠腺瘤性息肉关系的研究[J].中华循证医学杂志,2016,16(5):513-516 [9]孙颖,李诺,温艳惠,等.幽门螺杆菌感染与结肠息肉相关性研究[J].中国实验诊断学,2017,21(4):573-575. [10]饶银花,骆子义.幽门螺杆菌感染:结直肠息肉发生的独立危险因素[J].胃肠病学和肝病学杂志,2018,27(10):1139-1143. [11]Wang F,Sun MY,Shi SL,et al.Helicobacter pylori infection and normal colorectal mucosa-adenomatous polyp-adenocarcinoma sequence:a meta-analysis of 27 case-control studies[J].Colorectal Dis,2014,16(4):246-252. [12]严波,杨善峰,李祥.大肠息肉与幽门螺旋杆菌感染的相关性分析[J].蚌埠医学院学,2019,44(11):1511-1512. [13]Selgrad M,Bornschein J,Kandulski A,et al.Helicobacter pylori rather than gastrin is associated with the occurrence of colon tumors[J].Int J Cancer,2014,135(5):1127-1131. [14]付成峰.幽门螺旋杆菌与大肠息肉发生、复发及癌变的关系[D].暨南大学,2018. [15]Jones M,Helliwell P,Pritchard C,et al.Helicobacter pylori and colorectal tumors:etiological relationship[J].World Oncology Surgery,2007(5):51. [16]张静,鲁晓岚,赵刚,等.肠毒素脆弱拟杆菌具核梭杆菌和幽门螺旋杆菌在肠道内富集度与结直肠癌的关系[J].中华肿瘤杂志,2018,40(2):99-104. [17]付成锋,杨宏昌,麦毅贤,等.幽门螺杆菌感染与大肠息肉发病关系探讨[J].临床消化病杂志,2018(5):298-301. [18]Nam JH,Hong CW,Kim BC,et al.Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms[J].Cancer Causes Control,2017,28(2):107-115. [19]Wu Q,Yang P,Xu P.et al.Association between Helicobacter pylori infection and the risk of colorectal neoplasia:a systematic review and meta-analysis[J].Colorectal Dis,2013,15(7):e352-e364. [20]Fujimori S,Kishida T,Kobayashi T,et al.Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma,especially in women[J].J Gastroenterol,2005,40(9):887-893. [21]Stor Z,Blagus R,Tropea A,et al.Net survival of patients with colorectal cancer: a comparison of two periodsv[J].Updates Surg,2019,71(4):687-694. [22]Aslan A,Erdem H,Celik MA,et al.Investigation of Insulin-Like Growth Factor-1 (IGF-1), P53, and Wilms’ Tumor 1 (WT1) Expression Levels in the Colon Polyp Subtypes in Colon Cancer[J].Med Sci Monit,2019(25):5510-5517. [23]Brim H,Zahaf M,Laiyemo AO,et al.Helicobacter pylori infection in the stomach is associated with an increased risk of African-American intestinal polyps[J].BMC Cancer,2014,14(1):1-7. [24]Butt J,Varga MG,Blot WJ,et al.Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States[J].Gastroenterology,2019,156(1):175-186. [25]Abbass K,Gul W,Markert R,et al.Association of helicobacter pylori infection with colorectal and colorectal cancer development[J].Southern Medicine JBI,2011(104):473-476. [26]Boyuk B,Ozgur A,Atalay H,et al.Helicobacter pylori infection coexisting with intestinal metaplasia is not associated with colorectal neoplasms[J].Prz Gastroenterol,2019,14(2):133-139. [27]Siddheshwar RK,Muhammad KB,Gray JC,et al.Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma[J].Am J Gastroenterol,2001,96(1):84-88. [28]Kumar A,Kim M,Lukin DJ.Helicobacter pylori is associated with increased risk of serrated colonic polyps:analysis of risk factors for serrated polyps[J].Indian J Gastroenterol,2018,37(3):235-242. [29]董一凡,郭涛,杨红,等.幽门螺杆菌感染与结直肠息肉及结直肠癌的相关性分析[J].中华内科杂志,2019(2):139-142. [30]魏以召,常玉英,谢静.幽门螺杆菌感染与结肠息肉、结肠癌的相关性[J].实用医学杂志,2019,35(7):1120-1123. [31]江开晰,谢彬,王继周.幽门螺旋杆菌感染与结肠癌发生的相关性研究[J].黑龙江医学,2018(5):448-449. [32]Yang F,Xu YL,Zhu RF.Helicobacter pylori infection and the risk of colorectal carcinoma:a systematic review and meta-analysis[J].Minerva Med,2019,110(5):464-470. [33]Chen XZ,Schottker B,Castro FA,et al.Relationship between Helicobacter pylori infection,chronic atrophic gastritis and the risk of colon, pancreatic,and gastric cancer:a 10-year follow-up of the Esther cohort study[J].Oncotarget,2016,7(13):17182-17193. [34]王洪,周元坤,车海军,等.胃泌素的表达与结直肠肿瘤的发生和增殖有关[J].中国综合临床,2008,24(7):640-642. [35]叶乐驰,郑晨果,李霞,等.幽门螺杆菌感染对结直肠癌发生的影响[J].实用医学杂志,2010(22):4071-4074. [36]张雪梅,阮君山,刘丽娜,等.幽门螺杆菌、高胃泌素血症对结直肠癌形成的影响[J].西安交通大学学报(医学版),2012(3):316-320. [37]朱依谆,殷明.药理学(第八版)[D].北京:人民卫生出版社,2016:272. [38]孙根林,王建荣,游善喜.塞来昔布治疗结直肠息肉的研究[J].实用临床医药杂志,2016(19):141-142. [39]房静远,时永全,陈萦晅,等.中国中国结直肠癌预防共识意见(2016年,上海)[J].胃肠病学,2016,21(11):668-686. [40]王晨阳,唐春,赵晓璠,等.抑制胃酸对大鼠空肠菌群结构和组成的影响[J].肠外与肠内营养,2017,24(1):46-51. [41]李林山,刘学进,周洪涛.幽门螺旋杆菌与结直肠癌的关系研究[J].中国现代医生,2016,54(19):91-93.